Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04186741
Other study ID # IMO
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2021
Est. completion date June 2022

Study information

Verified date December 2019
Source Assiut University
Contact Nahla A Mousa
Phone 01142338708
Email totydodeg@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Audiological evaluation performed to patients on hyperbaric oxygen therapy to see its effects on middle ear pressure


Description:

Thirty patients will be recruited from center pf hyperbaric oxygen therapy Every patient who received HBOT was submitted for Demographic data:age,gender,condition raquiring HBOT,use of analgesics,history of diabets ,cardiovascular or respiratory disease ,psychatric illness,smoking history facial/ENT problems and previous HBOT problems then tympanometry and basic pure tone audiometry including air and bone conduction is done following each of the first five treatment


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date June 2022
Est. primary completion date October 2021
Accepts healthy volunteers No
Gender All
Age group 10 Years and older
Eligibility Inclusion Criteria:

- patients above 18 years old already recieving hyperbaric oxygen therapy for treatment of other medical conditions required treatment by it as in diabetic foot

Exclusion Criteria:

- patients who already had tympanostomy tubes

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Hyperbaric oxygen
Patients already on treatment by hyperbaric oxygen therapy for medical conditions requiring treatment by it

Locations

Country Name City State
Egypt Assiut university Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Yamamoto Y, Noguchi Y, Enomoto M, Yagishita K, Kitamura K. Otological complications associated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2487-93. doi: 10.1007/s00405-015-3845-9. Epub 2015 Dec 9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changing in middle ear pressure Measuring middle ear pressure before exposure ro hyperbaric oxygen and following each of the first five treatments Through completion of study after 2 years